论文部分内容阅读
到2050年,中国65岁以上人口预计将增加约1.9亿。此外,慢性疾病现在占中国疾病负担的80%以上。无怪乎中国已然成为全球第二大医药市场,也无怪乎根据麦肯锡季刊报告显示,中国的创新经费到2020年将达到1万亿美元的规模。中国经济近年来发生了根本性的变化,正在为科技的卓越进步打下坚实的基础。尤其是,中国参与了与疾病的斗争,而且,人们有理由相信这个国家将在未来的生命科学研究中发挥核心作用。
By 2050, China’s population over the age of 65 is expected to increase by about 190 million. In addition, chronic diseases now account for more than 80% of the disease burden in China. No wonder China has become the world’s second largest pharmaceutical market, no wonder According to the McKinsey quarterly report shows that China’s innovation funding will reach 1 trillion US dollars by 2020 scale. China’s economy has undergone fundamental changes in recent years and is laying a solid foundation for the remarkable progress of science and technology. In particular, China is involved in the fight against the disease, and there is reason to believe that this country will play a central role in future life science research.